J&J confirms talks with Actelion over pharma deal
Johnson & Johnson, the world’s largest healthcare group, confirmed on Friday it is in preliminary discussions with Actelion, Europe’s largest biotechnology company, over a potential deal. Its statement came after days of speculation among investors that J&J had been preparing a bid for Actelion, although the Switzerland-based biotech had earlier warned “there can be no certainty that a transaction will result” from the J&J approach. People close […]